106 related articles for article (PubMed ID: 18682520)
1. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study.
Roede BM; Bresser P; Bindels PJ; Kok A; Prins M; ter Riet G; Geskus RB; Herings RM; Prins JM
Thorax; 2008 Nov; 63(11):968-73. PubMed ID: 18682520
[TBL] [Abstract][Full Text] [Related]
2. Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD.
Roede BM; Bresser P; Prins JM; Schellevis F; Verheij TJ; Bindels PJ
Eur Respir J; 2009 Feb; 33(2):282-8. PubMed ID: 19047316
[TBL] [Abstract][Full Text] [Related]
3. Measuring exacerbations in obstructive lung disease.
Velthove KJ; Souverein PC; van Solinge WW; Leufkens HG; Lammers JW
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):367-74. PubMed ID: 20014167
[TBL] [Abstract][Full Text] [Related]
4. Effects of corticosteroid use on readmission in obstructive lung disease.
Velthove KJ; Souverein PC; van Solinge WW; Leufkens HG; Lammers JW
Respir Med; 2010 Feb; 104(2):211-8. PubMed ID: 19781925
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
6. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
7. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
8. Medication changes prior to hospitalization for obstructive lung disease: a case-crossover study.
Velthove KJ; Leufkens HG; Schweizer RC; van Solinge WW; Souverein PC
Ann Pharmacother; 2010 Feb; 44(2):267-73. PubMed ID: 20071496
[TBL] [Abstract][Full Text] [Related]
9. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
[TBL] [Abstract][Full Text] [Related]
11. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
12. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
13. Use of inhaled corticosteroids and the risk of non-fatal acute myocardial infarction.
de Vries F; Pouwels S; Bracke M; Lammers JW; Leufkens H; Klungel O; van Staa T
J Hypertens; 2008 Jan; 26(1):124-9. PubMed ID: 18090549
[TBL] [Abstract][Full Text] [Related]
14. Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based study.
van Wijk BL; Avorn J; Solomon DH; Klungel OH; Heerdink ER; de Boer A; Brookhart AM
J Hypertens; 2007 Mar; 25(3):689-97. PubMed ID: 17278986
[TBL] [Abstract][Full Text] [Related]
15. Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition.
Ingebrigtsen TS; Marott JL; Lange P; Hallas J; Nordestgaard BG; Vestbo J
Respir Med; 2015 Dec; 109(12):1562-8. PubMed ID: 26560643
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
Kiri VA; Fabbri LM; Davis KJ; Soriano JB
Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics and reduced risk of COPD re-exacerbations.
Antoniu SA
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):309-11. PubMed ID: 19670990
[TBL] [Abstract][Full Text] [Related]
18. Acute exacerbations of obstructive lung disease. What to do when immediate care is crucial.
Fromm RE; Varon J
Postgrad Med; 1994 Jun; 95(8):101-6. PubMed ID: 7911236
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
20. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
